A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma (Q41841115)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 October 2013
edit
Language Label Description Also known as
English
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
scientific article published on 22 October 2013

    Statements

    A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma (English)
    Vidyalakshmi Chandramohan

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit